Tolerability of Goat Milk Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger
NCT05180578 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-05-22
Summary
Eosinophilic esophagitis (EoE) is a chronic immune mediated disease characterized by eosinophilic infiltration in esophageal epithelium and resulting in esophageal dysfunction.
While the exact pathogenesis is yet to be elucidated, EoE is considered an atopic disease. This classification is in part due to the inflammatory infiltrate of eosinophils, basophils and T-cells producing Th2 cytokines, yet it may also be triggered by environmental allergens. In addition, the rates of atopy are approximately 3 times higher in patients with EoE than in the general population. Furthermore, and most convincing, EoE is successfully managed with dietary exclusion of triggering groups in both pediatric and adult patients, further confirming the atopic nature of the disease.
The most frequent dietary trigger for EoE is milk, but there is limited data on the cross-reactivity of milk from other species. Guidelines addressing the diagnosis and treatment of EoE in both children and adults have not addressed the use of non-bovine milk in patients with cow's milk triggered EoE.
Restrictive diets are often challenging for patients and contribute to a reduced quality of life. Our own, anecdotal experience in two patients with milk triggered EoE who requested to introduce goat's milk into the patients' diet were that reintroduction did not trigger a clinical or histological flare of EoE. These cases of successful introduction of non-bovine milk introduces the possibility that a milk-free diet need not necessarily be exclusive of all species.
The aim of this study is to assess tolerability and safety of goat's milk in patients with EoE in whom cow's milk has been confirmed to be a trigger food for their disease.
Conditions
- Eosinophilic Esophagitis
Interventions
- OTHER
-
Goat milk diet
Elimination of cow milk from diet . Goat milk containing diet.
Sponsors & Collaborators
-
Shaare Zedek Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-12
- Primary Completion
- 2025-10-31
- Completion
- 2025-10-31
Countries
- Israel
Study Locations
More Related Trials
-
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
NCT06665971 ·Status: RECRUITING ·Phase: PHASE4
-
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
NCT03822325 ·Status: ACTIVE_NOT_RECRUITING
-
Sensory Processing Issues in Eosinophilic Esophagitis
NCT06187753 ·Status: RECRUITING
-
EDN and Eosinophilic Esophagitis
NCT06387030 ·Status: RECRUITING ·Phase: NA
-
Swallowing Characteristics of Pediatric Patients With Eosinophilic Esophagitis
NCT04704752 ·Status: COMPLETED
-
Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
NCT00123656 ·Status: COMPLETED ·Phase: PHASE2
-
Non-endoscopic Tracking of Disease Activity in Eosinophilic Esophagitis
NCT03834298 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population
NCT05176249 ·Status: ACTIVE_NOT_RECRUITING
-
Eosinophilic Esophagitis Clinical Therapy Comparison Trial
NCT01821898 ·Status: TERMINATED ·Phase: PHASE2
-
Eating With Eosinophilic Esophagitis (EoE)
NCT03581838 ·Status: COMPLETED
-
Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
NCT01865825 ·Status: COMPLETED
-
Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
NCT00939263 ·Status: UNKNOWN
-
Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
NCT01631591 ·Status: COMPLETED
-
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
NCT02778867 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
NCT01479231 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation
NCT00667524 ·Status: COMPLETED
-
Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis
NCT01386112 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
NCT06705387 ·Status: RECRUITING ·Phase: PHASE2
-
Dupilumab for Eosinophilic Esophagitis With Severe Strictures
NCT06352073 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Food Antigen in Eosinophilic Esophagitis
NCT02434705 ·Status: COMPLETED
-
Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric Patients
NCT03069573 ·Status: COMPLETED
-
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
NCT01022970 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolomic Profiling of Eosinophilic Esophagitis
NCT03803527 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
NCT02353078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
NCT02523118 ·Status: RECRUITING